Vistin Pharma ASA:
Stock exchange announcements

31/5/2023

Vistin Pharma ASA: Mandatory notification of trade

30/5/2023

Vistin Pharma ASA: Mandatory notification of trade

22/5/2023

Vistin Pharma ASA: Minutes from the Annual General Meeting 2023

12/5/2023

Disclosure of voting rights at AGM in Vistin Pharma ASA

11/5/2023

Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø

28/4/2023

Notice of Annual General Meeting in Vistin Pharma ASA

27/4/2023

Vistin Pharma ASA: Annual Report for 2022

27/4/2023

Vistin Pharma ASA: First quarter 2023 financial results

20/4/2023

Vistin Pharma ASA: Invitation to Q1 2023 conference call

17/2/2023

Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results

10/2/2023

Vistin Pharma ASA: Invitation to Q4 2022 conference call

9/12/2022

Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft

26/10/2022

Vistin Pharma ASA: Third quarter and YTD 2022 financial results

18/10/2022

Vistin Pharma ASA: Invitation to Q3 2022 conference call

11/10/2022

Vistin Pharma ASA: Invitation to Q2 2022 conference call

19/8/2022

Vistin Pharma ASA: Second quarter and first half 2022 financial results

19/5/2022

Vistin Pharma ASA: Minutes from the annual general meeting 2022

28/4/2022

Vistin Pharma ASA: Notice of Annual General Meeting

27/4/2022

Vistin Pharma ASA: Annual Report for 2021

27/4/2022

Vistin Pharma ASA: First quarter 2022 financial results

20/4/2022

Vistin Pharma ASA: Invitation to Q1 2022 conference call

16/2/2022

New interim CEO

8/2/2022

Vistin Pharma ASA: Invitation to Q4 2021 conference call